These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 8940339)

  • 1. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
    Dalkin AC; Gilrain JT; Bradshaw D; Myers CE
    Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP.
    Wang QF; Tilly KI; Tilly JL; Preffer F; Schneyer AL; Crowley WF; Sluss PM
    Endocrinology; 1996 Dec; 137(12):5476-83. PubMed ID: 8940374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells.
    Fujii Y; Kawakami S; Okada Y; Kageyama Y; Kihara K
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E927-31. PubMed ID: 14761877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
    Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
    Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin.
    Dalkin AC; Haisenleder DJ; Yasin M; Gilrain JT; Marshall JC
    Endocrinology; 1996 Feb; 137(2):548-54. PubMed ID: 8593801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and localization of activin subunits and follistatins in tissues from men with high grade prostate cancer.
    Thomas TZ; Wang H; Niclasen P; O'Bryan MK; Evans LW; Groome NP; Pedersen J; Risbridger GP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3851-8. PubMed ID: 9360551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145.
    McPherson SJ; Thomas TZ; Wang H; Gurusinghe CJ; Risbridger GP
    J Endocrinol; 1997 Sep; 154(3):535-45. PubMed ID: 9379131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues.
    van Schaik RH; Wierikx CD; Timmerman MA; Oomen MH; van Weerden WM; van der Kwast TH; van Steenbrugge GJ; de Jong FH
    Br J Cancer; 2000 Jan; 82(1):112-7. PubMed ID: 10638976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activin regulates betaA-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumor cells.
    Di Simone N; Hall HA; Welt C; Schneyer AL
    Endocrinology; 1998 Mar; 139(3):1147-55. PubMed ID: 9492049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells.
    Bilezikjian LM; Corrigan AZ; Blount AL; Chen Y; Vale WW
    Endocrinology; 2001 Mar; 142(3):1065-72. PubMed ID: 11181520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex difference in the action of activin-A on cell proliferation of differentiating rat gonad.
    Kaipia A; Toppari J; Huhtaniemi I; Paranko J
    Endocrinology; 1994 May; 134(5):2165-70. PubMed ID: 8156918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of activin A and follistatin core proteins by human prostate tumor cell lines.
    McPherson SJ; Mellor SL; Wang H; Evans LW; Groome NP; Risbridger GP
    Endocrinology; 1999 Nov; 140(11):5303-9. PubMed ID: 10537161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of prostate branching morphogenesis by activin A and follistatin.
    Cancilla B; Jarred RA; Wang H; Mellor SL; Cunha GR; Risbridger GP
    Dev Biol; 2001 Sep; 237(1):145-58. PubMed ID: 11518512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activin A stimulates AKR1C3 expression and growth in human prostate cancer.
    Hofland J; van Weerden WM; Steenbergen J; Dits NF; Jenster G; de Jong FH
    Endocrinology; 2012 Dec; 153(12):5726-34. PubMed ID: 23024260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an activin-follistatin growth modulatory system in the human prostate: secretion and biological activity in primary cultures of prostatic epithelial cells.
    Wang Q; Tabatabaei S; Planz B; Lin CW; Sluss PM
    J Urol; 1999 Apr; 161(4):1378-84. PubMed ID: 10081911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
    Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
    Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP.
    Zhang Z; Zhao Y; Batres Y; Lin MF; Ying SY
    Biochem Biophys Res Commun; 1997 May; 234(2):362-5. PubMed ID: 9177276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors.
    Bilezikjian LM; Corrigan AZ; Blount AL; Vale WW
    Endocrinology; 1996 Oct; 137(10):4277-84. PubMed ID: 8828487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): regulation by cell surface follistatin.
    Delbaere A; Sidis Y; Schneyer AL
    Endocrinology; 1999 Jun; 140(6):2463-70. PubMed ID: 10342830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibins, activins, and follistatins: expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasia.
    Thomas TZ; Chapman SM; Hong W; Gurusingfhe C; Mellor SL; Fletcher R; Pedersen J; Risbridger GP
    Prostate; 1998 Jan; 34(1):34-43. PubMed ID: 9428386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.